Quantib (Quantitative Imaging Biomarkers) strives for faster and more accurate diagnosis, supporting adequate and timely patient care. Using advanced machine learning and deep learning techniques, Quantib’s algorithms can detect changes in tissue sooner than would be possible with the naked eye. Great benefits lie in the standardization of measurements, removal of inter- and intra-observer variance, and acceleration and refining of the diagnosis process all offered by Quantib’s tools.

Currently, Quantib has two products with FDA and/or CE certification, both focused on brain volume measurements and lesion detection on MRI scans. Future products include MRI prostate and MRI breast analysis software.